| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.35 | 2e-20 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.32 | 2e-17 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.3 | 5e-15 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-11 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |